Drug interactions between FluMist and Kinrix
| Results for the following 2 drugs: |
|---|
| FluMist (influenza virus vaccine, live, trivalent) |
| Kinrix (diphtheria toxoid/pertussis, acellular/poliovirus vaccine, inactivated/tetanus toxoid) |
Interactions between your selected drugs
poliovirus vaccine, inactivated ↔ influenza virus vaccine, live, trivalent
Applies to:Kinrix (diphtheria toxoid/pertussis, acellular/poliovirus vaccine, inactivated/tetanus toxoid) and FluMist (influenza virus vaccine, live, trivalent)
The safety and immunogenicity of live influenza virus vaccines when administered concurrently with other vaccines have not been determined. Clinical studies for FluMist (live influenza virus vaccine intranasal spray) have excluded subjects who received any inactivated or subunit vaccine within two weeks of enrollment. Data concerning use with live vaccines are limited to the measles, mumps and rubella vaccine and the varicella vaccine. In a study consisting of 1,245 children 12 to 15 months of age, adverse events observed during concurrent administration of FluMist with these vaccines were similar to the adverse effects reported in other clinical trials for FluMist. No evidence of interference with immune responses to any of the study vaccines was observed. Concurrent administration in children greater than 15 months of age has not been studied.
tetanus toxoid ↔ influenza virus vaccine, live, trivalent
Applies to:Kinrix (diphtheria toxoid/pertussis, acellular/poliovirus vaccine, inactivated/tetanus toxoid) and FluMist (influenza virus vaccine, live, trivalent)
The safety and immunogenicity of live influenza virus vaccines when administered concurrently with other vaccines have not been determined. Clinical studies for FluMist (live influenza virus vaccine intranasal spray) have excluded subjects who received any inactivated or subunit vaccine within two weeks of enrollment. Data concerning use with live vaccines are limited to the measles, mumps and rubella vaccine and the varicella vaccine. In a study consisting of 1,245 children 12 to 15 months of age, adverse events observed during concurrent administration of FluMist with these vaccines were similar to the adverse effects reported in other clinical trials for FluMist. No evidence of interference with immune responses to any of the study vaccines was observed. Concurrent administration in children greater than 15 months of age has not been studied.
diphtheria toxoid ↔ influenza virus vaccine, live, trivalent
Applies to:Kinrix (diphtheria toxoid/pertussis, acellular/poliovirus vaccine, inactivated/tetanus toxoid) and FluMist (influenza virus vaccine, live, trivalent)
The safety and immunogenicity of live influenza virus vaccines when administered concurrently with other vaccines have not been determined. Clinical studies for FluMist (live influenza virus vaccine intranasal spray) have excluded subjects who received any inactivated or subunit vaccine within two weeks of enrollment. Data concerning use with live vaccines are limited to the measles, mumps and rubella vaccine and the varicella vaccine. In a study consisting of 1,245 children 12 to 15 months of age, adverse events observed during concurrent administration of FluMist with these vaccines were similar to the adverse effects reported in other clinical trials for FluMist. No evidence of interference with immune responses to any of the study vaccines was observed. Concurrent administration in children greater than 15 months of age has not been studied.
pertussis, acellular ↔ influenza virus vaccine, live, trivalent
Applies to:Kinrix (diphtheria toxoid/pertussis, acellular/poliovirus vaccine, inactivated/tetanus toxoid) and FluMist (influenza virus vaccine, live, trivalent)
The safety and immunogenicity of live influenza virus vaccines when administered concurrently with other vaccines have not been determined. Clinical studies for FluMist (live influenza virus vaccine intranasal spray) have excluded subjects who received any inactivated or subunit vaccine within two weeks of enrollment. Data concerning use with live vaccines are limited to the measles, mumps and rubella vaccine and the varicella vaccine. In a study consisting of 1,245 children 12 to 15 months of age, adverse events observed during concurrent administration of FluMist with these vaccines were similar to the adverse effects reported in other clinical trials for FluMist. No evidence of interference with immune responses to any of the study vaccines was observed. Concurrent administration in children greater than 15 months of age has not been studied.
See also...
Drug Interaction Classification
The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2012 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
